Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals [Yahoo! Finance]
Disc Medicine, Inc. (IRON)
Company Research
Source: Yahoo! Finance
Disc Medicine (IRON) has drawn fresh attention after recent share price moves, with the stock up about 3% over the past day but showing a negative return over the past month and past 3 months. See our latest analysis for Disc Medicine. The latest 3.0% 1 day share price return and 2.8% 7 day share price return sit against weaker recent momentum, with the 30 day and 90 day share price returns both negative while the 1 year and 3 year total shareholder returns remain firmly positive. If Disc Medicine's recent swings have you looking wider, this could be a good moment to scan our screener of 32 healthcare AI stocks for other ideas in the space. With IRON trading at about a 49% discount to one intrinsic estimate and a 51% discount to the average analyst target, yet posting a net loss and zero revenue, is this a mispriced growth story, or is the market already looking ahead? Preferred Multiple of Price-to-Book: Is it justified? At a P/B of 3.4x, Disc Medicine sits at a premium
Show less
Read more
Impact Snapshot
Event Time:
IRON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRON alerts
High impacting Disc Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
IRON
News
- IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law FirmBusiness Wire
- IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP InvestigatesGlobeNewswire
- IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc MedicinePR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRONGlobeNewswire
- Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.MarketBeat
IRON
Earnings
- 2/26/26 - Miss
IRON
Sec Filings
- 3/4/26 - Form 4
- 3/2/26 - Form 144
- 2/27/26 - Form 4
- IRON's page on the SEC website